A Higher Standard

IMPORTANT ANNOUNCEMENT: COVID-19 Action Plan

Given the recent declarations of a national emergency and our concern for all Abarcans, clients, and members, all Abarcans will be working remotely, starting today, Monday, March 16th, except for some límited roles. Rest assured that our services will continue...

3-19-2020

Abarca_Covid19 Action Plan

January is Cervical Health Awareness Month

Abarca stands in solidarity with the national campaign to raise awareness of cervical cancer, HPV (human papillomavirus) disease, and the importance of early detection. According to the National Cervical Cancer Coalition (NCCC), more than 13,000 women in the U.S. are...

1-29-2020

Abarca highlights: January is Cervical Health Awareness Month

A Look Back at 2019

While there is never a bad time to be an Abarcan, 2019 was our best year yet. Here’s a look back at a few of our proudest moments: Employee-led initiatives. Abarca team members took the reins in creating exciting new...

1-17-2020

Abarca Health: Image

A First: Real Value in Medicaid

Prescription drug prices are soaring in the US, particularly for specialty medications. To deal with escalating costs, forward-thinking health plans and pharmacy benefit managers (PBMs) are exploring value-based contracts as an alternative to traditional fee-for-service payment models. For one Medicaid...

1-14-2020

pharmacy benefit management

4 Tips for Value-Based Contracting

Many in healthcare are looking to value-based agreements with pharmaceutical manufacturers as a way to generate savings for health plans and ensure that medications provide the intended outcomes for members. Although there are relatively few of these agreements in place,...

12-4-2019

pharmacy benefit management

Abarca, Amgen Enter Outcome-Based Agreement for Enbrel

AVENTURA, FL -- Abarca, a pharmacy benefit manager (PBM) that is disrupting the industry with an entirely new approach to technology and business practices, today announced it has entered into an outcomes-based contract with Amgen (NASDAQ: AMGN) for the drug...

12-3-2019

healthcare administration platform